Cumberland Pharmaceuticals (CPIX) Reports Q1 Loss of $0.13

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of ($0.13). Revenue for the quarter came in at $9.1 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Centrus Energy signs $900M DOE contract for uranium enrichment
• Cumberland Pharmaceuticals sells branded drug line to Apotex for $100M